What Is Pott’s Disease? Causes, Symptoms, and Treatment

Pott’s disease is tuberculosis of the spine, a destructive infection in which the bacterium that causes TB settles in one or more vertebrae, gradually eating into bone, forming abscesses, and sometimes collapsing the spine into the sharply angled hunchback deformity that first brought it to medical attention in the eighteenth century. Though far less common today in high-income countries than it once was, spinal TB remains a serious problem worldwide, and its slow, insidious onset means it is often diagnosed late, when significant damage has already occurred.

How Tuberculosis Reaches the Spine

Pott’s disease is caused by Mycobacterium tuberculosis, the same organism responsible for pulmonary TB. In most cases the infection does not begin in the spine. Instead, bacteria enter the bloodstream from a primary site, usually the lungs, and travel to the richly supplied blood vessels feeding the vertebral bodies.¹ Once lodged in bone, the bacteria multiply slowly, producing a creeping destruction of the vertebral body and the disc space between affected vertebrae. The thoracic and thoracolumbar spine are the most frequently involved regions, though any segment from the neck to the sacrum can be affected.

Because the bacteria reach the spine through the blood, a person can develop spinal TB months or even years after the initial lung infection, sometimes long after the pulmonary disease has apparently resolved. This is part of what makes Pott’s disease tricky to recognize: there may be no cough, no obvious lung problem, and no reason to think of TB at all when a patient shows up with back pain.

Who Is Most at Risk

Spinal TB tracks closely with the risk factors for tuberculosis in general. Poverty, overcrowding, malnutrition, HIV infection, and alcohol or drug use all raise the odds substantially.² Low-income countries bear the heaviest burden, but pockets of high TB incidence also exist in deprived urban areas within wealthier nations, particularly among immigrant communities and people living with HIV. Anyone whose immune system is compromised, whether from HIV, diabetes, long-term steroid use, or organ transplantation, faces an elevated risk of TB reactivating in extrapulmonary sites like the spine.

Children are not spared. When Sir Percivall Pott first described the condition in 1779 and 1782, the majority of his patients were infants and young children.³ In parts of the world where childhood TB vaccination coverage is incomplete or where drug-resistant strains circulate, pediatric spinal TB still occurs.

Symptoms and How They Develop

Pott’s disease earns its reputation for being sneaky. Symptoms come on gradually, and early complaints can be maddeningly vague. The hallmark presentation includes back pain, localized spinal tenderness, general constitutional symptoms like low-grade fever, night sweats, weight loss, and fatigue, and eventually visible spinal deformity or neurological problems.⁴

Back pain is usually the first thing patients notice. It tends to be constant, dull, and worse at night or with activity. Because back pain is extraordinarily common and almost always caused by something benign, TB is rarely on anyone’s radar during the early weeks or months. Constitutional symptoms like night sweats and unexplained weight loss, when present, are important clues that push the diagnosis toward infection or malignancy rather than a simple muscle strain or disc problem.

As the disease progresses and vertebral bodies weaken, the spine can buckle forward, producing a kyphotic deformity, the classic “hunchback” angulation. In severe cases this deformity becomes the most visible feature of the disease. Paraplegia, the loss of motor and sensory function in the legs, is the most feared complication and can develop through several routes: direct pressure on the spinal cord from abscess or bone fragments, inflammatory swelling, or spinal instability.⁵

Late-Onset Paralysis After the Infection Has Healed

One of the more unsettling aspects of Pott’s disease is that neurological damage can appear years after the active infection has been treated and apparently cured. This “late onset” paraplegia happens when a sharp kyphotic deformity that formed during the active phase gradually compresses or stretches the spinal cord over time.⁶ In healed disease the mechanism is different from active disease: rather than inflammation and pus pressing on the cord, the problem is a fixed bony ridge on the inside of the deformity that slowly damages cord tissue.⁵ This means that a patient who was successfully treated for spinal TB decades earlier can present with new leg weakness or numbness, requiring careful reassessment and sometimes surgery to relieve the cord compression.

Complications Beyond the Spine

Pott’s disease doesn’t always stay confined to the vertebrae. Abscesses that form around the infected bone can track along natural tissue planes and show up far from the original site. One well-known example is the psoas abscess, where infected material migrates from the lumbar spine into the psoas muscle, the large muscle that runs from the lower spine through the pelvis to the thigh. These collections can become very large.⁷ In one reported case during pregnancy, bilateral psoas abscesses measured up to 17 centimeters across.⁸ A psoas abscess can cause hip pain, a limp, or groin swelling that might not immediately suggest a spinal origin, adding another layer of diagnostic confusion.

Progressive kyphosis itself brings long-term consequences even after the infection resolves. Severe angular deformity affects breathing mechanics, causes chronic pain, and profoundly alters posture. In children the picture is even more complex, because growth can either improve or worsen the deformity over time.

How Pott’s Disease Is Diagnosed

Pinning down a diagnosis of spinal TB requires a combination of imaging, lab work, and often tissue sampling. No single test is definitive on its own, and the infection has to be distinguished from other conditions that can look very similar, particularly pyogenic (ordinary bacterial) spondylitis and sometimes spinal tumors.

MRI is the most useful imaging tool. It shows soft-tissue detail that plain X-rays miss, including abscesses, disc involvement, and the extent of cord compression. On MRI, several patterns favor TB over a common bacterial infection: a well-defined paraspinal abscess with thin, smooth walls; spread of the infection under the spinal ligaments across three or more vertebral levels; and involvement of multiple vertebral bodies, especially in the thoracic spine.⁹ Advanced imaging including CT and PET-CT can further define the extent of bone destruction, identify calcifications within abscesses, and help plan surgery or guide needle biopsies.¹⁰ While these imaging features are suggestive rather than conclusive, a scoring system incorporating multiple MRI features has shown high accuracy in distinguishing TB spondylitis from pyogenic infection.¹¹

Imaging alone, however, is not enough. A confirmed diagnosis generally requires identifying the TB bacterium in tissue or fluid obtained through a CT-guided biopsy or surgical sampling. Traditional culture, while highly specific, is slow and detects the organism in only about half of cases.¹² Molecular tests like GeneXpert, which detect TB DNA directly from a tissue sample, have significantly improved the speed and sensitivity of diagnosis. One prospective study found GeneXpert positive in over 90% of confirmed spinal TB cases, including all cases where histopathology was inconclusive.¹² Combining molecular testing with histopathology pushes diagnostic sensitivity even higher.¹³

In practice, clinicians often have to make a presumptive diagnosis based on a combination of clinical signs, imaging appearance, lab markers, and the patient’s background. Blood tests like the erythrocyte sedimentation rate (ESR) and C-reactive protein are usually elevated but are not specific to TB. Research into more precise biomarkers for monitoring spinal TB is ongoing, though no multi-marker panel has yet been validated for routine use.¹⁴

Telling TB Apart From Other Spinal Infections

One of the hardest problems for clinicians is separating spinal TB from pyogenic spondylitis, the more common bacterial spine infection. Both can cause back pain, fever, and elevated inflammatory markers, and both can look alarming on MRI. Distinguishing them matters enormously because the treatments are completely different: pyogenic infections call for weeks of targeted antibiotics, while spinal TB requires months of multi-drug anti-tubercular therapy.¹⁵

Certain MRI features lean strongly toward TB: well-defined paraspinal collections with thin smooth walls, the spread of disease under spinal ligaments across multiple levels, and bone abscesses within the vertebral body itself. Pyogenic infections, by contrast, tend to produce more diffuse, poorly marginated collections and often involve the facet joints, a finding uncommon in TB.¹¹ Even so, overlap exists, and tissue sampling for culture and molecular testing remains the gold standard for a definitive answer.

Anti-Tubercular Drug Therapy

The backbone of treatment for Pott’s disease is prolonged multi-drug chemotherapy. The World Health Organization classifies spinal TB as a severe form of extrapulmonary tuberculosis, and the standard regimen uses multiple drugs simultaneously to attack the different metabolic states of the bacterium.¹⁶

A typical course follows what is sometimes called the “middle-path regimen”: two months of an intensive phase combining four drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol), followed by a longer continuation phase of isoniazid and rifampicin, often lasting ten months or more.¹⁷ Doctors monitor progress with repeat imaging and blood markers, and extend treatment if the disease hasn’t fully healed by the time the planned course ends.

There has been ongoing debate about how long treatment really needs to last. A meta-analysis pooling data from multiple trials found that about 90% of patients treated for six months achieved healed status at final follow-up, a rate statistically equivalent to patients treated for nine months or longer.¹⁸ Shorter courses are attractive because they improve patient adherence and reduce side effects, but many clinicians remain cautious and prefer to continue treatment until imaging confirms resolution, which often takes longer than six months in practice. The evidence is enough to consider a shorter course in straightforward cases, but not enough for it to be universally adopted.

Drug-Resistant Spinal TB

Multi-drug-resistant TB (MDR-TB), where the bacteria are resistant to at least isoniazid and rifampicin, poses a much harder treatment challenge. Standard first-line drugs simply won’t work, and the regimens required instead are longer, more toxic, and less well studied in the spine specifically. WHO guidelines call for at least five effective drugs, drawing from second-line agents, with treatment lasting a minimum of 18 to 24 months.¹⁹ Drug selection ideally relies on susceptibility testing from a tissue sample, but when that’s not available, doctors base their regimen on the patient’s drug exposure history and local resistance patterns.²⁰

Early molecular diagnosis of resistance, using tests like GeneXpert that can also detect rifampicin resistance, has been a genuine advance. Identifying resistance upfront rather than waiting weeks for conventional culture results means appropriate second-line drugs can be started sooner, improving outcomes.²¹

When Surgery Is Needed

Most patients with spinal TB can be treated with drugs alone, but surgery becomes necessary in certain situations: progressive neurological deterioration despite drug therapy, large abscesses that need draining, spinal instability from severe bone destruction, significant kyphosis, or failure to improve on medication.²² The goals of surgery are to decompress the spinal cord, remove infected tissue, correct or prevent further deformity, and stabilize the spine.

Surgical approaches vary depending on the location and extent of the disease. An anterior approach, entering from the front of the spine, allows direct access to the vertebral body where the infection typically sits and provides the opportunity to place a bone graft to reconstruct the collapsed segment. This technique has been shown to help prevent the progressive kyphosis that can otherwise develop after the acute infection heals.²³ Posterior instrumentation with screws and rods, either alone or combined with the anterior approach, provides additional stability and is increasingly used. The choice depends on how many vertebral levels are involved, where the disease is, and what the surgeon has access to in terms of resources and expertise.

Recovery and Rehabilitation

Even after successful drug treatment or surgery, recovery from Pott’s disease is not simply a matter of waiting for the drugs to work. Months of spinal pain, stiffness, muscle wasting, and in some cases neurological deficits leave patients deconditioned and functionally impaired. Structured physiotherapy plays a meaningful role. A case report documented marked improvement in spinal mobility, pain, respiratory function, sensory recovery, and overall functional independence after a six-week tailored rehabilitation program in a conservatively managed patient.²⁴

Rehabilitation goals depend on the severity of the disease and any residual neurological damage. For patients with paraplegia, the program may resemble spinal cord injury rehabilitation, focusing on mobility training, bowel and bladder management, and adaptation to assistive devices. For patients without neurological involvement, the emphasis shifts to restoring core strength, spinal flexibility, and confidence in normal movement. Bracing is sometimes used during the healing phase to limit spinal motion, though the evidence for bracing as a routine measure is debated.

Pott’s Disease in Children Versus Adults

The natural history of spinal TB differs in meaningful ways between children and adults. After the active infection heals, kyphotic deformity in adults tends to remain stable. In children, the picture is unpredictable. A study tracking children after healing found that deformity decreased in about 44%, increased in about 39%, and stayed the same in the remaining 17%.²⁵ The changes occurring during growth after the infection resolves can actually be more significant than the damage caused during the active disease itself.²⁵

This has practical implications. A child who appears to have a modest residual deformity at the end of treatment may still need long-term follow-up through skeletal maturity, because the kyphosis can worsen during growth spurts. Decisions about surgical correction in children are often more aggressive than in adults precisely because the consequences of a worsening curve over years of remaining growth can be severe.

An Ancient Disease Still Present Today

Pott’s disease is far from new. Spinal TB has been identified in human remains dating back thousands of years, and the characteristic vertebral destruction of Pott’s disease is one of the most recognizable signs of TB in archaeological skeletons.²⁶ Ancient Egyptian mummies and medieval European skeletons have been found with the telltale angular kyphosis and bone erosion. Modern molecular techniques can now extract and identify M. tuberculosis DNA from these ancient remains, confirming what morphological analysis long suggested.

Despite centuries of recognition and decades of effective drug therapy, spinal TB persists wherever tuberculosis itself persists. In sub-Saharan Africa, South Asia, and Southeast Asia, it remains a meaningful cause of chronic back pain, disability, and paraplegia. In high-income countries, cases are uncommon but not rare, and they cluster among immigrants from high-burden regions, people living with HIV, and other immunocompromised populations. The biggest practical danger in low-incidence settings is a long diagnostic delay because clinicians simply aren’t thinking about TB when someone walks in with back pain. That delay allows bone destruction and deformity to progress before treatment starts, which is why awareness of Pott’s disease remains relevant well beyond the regions where TB is endemic.